loading
Precedente Chiudi:
$1.21
Aprire:
$1.2
Volume 24 ore:
81,712
Relative Volume:
0.67
Capitalizzazione di mercato:
$14.51M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-2.1316
EPS:
-0.57
Flusso di cassa netto:
$-21.66M
1 W Prestazione:
+5.16%
1M Prestazione:
-1.62%
6M Prestazione:
-68.40%
1 anno Prestazione:
-58.51%
Intervallo 1D:
Value
$1.1895
$1.23
Intervallo di 1 settimana:
Value
$1.1299
$1.36
Portata 52W:
Value
$1.10
$7.333

Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile

Name
Nome
Nrx Pharmaceuticals Inc
Name
Telefono
484-254-6134
Name
Indirizzo
1201 ORANGE STREET, WILMINGTON
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
NRXP's Discussions on Twitter

Confronta NRXP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
NRXP 1.215 14.51M 0 -30.15M -21.66M -0.57
VRTX 449.26 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.72 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 600.42 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.28 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.11 24.89B 3.30B -501.07M 1.03B 11.54

Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie

pulisher
Nov 20, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Po - GuruFocus.com

Nov 20, 2024
pulisher
Nov 19, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 19, 2024
pulisher
Nov 19, 2024

Earnings call: NRx Pharmaceuticals projects profitability by 2025 - Investing.com UK

Nov 19, 2024
pulisher
Nov 19, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer - BioSpace

Nov 19, 2024
pulisher
Nov 18, 2024

NRx Pharmaceuticals Reports Progress in Drug Development - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

NRx Pharmaceuticals names Michael Abrams as new CFO - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

NRx Pharmaceuticals Names Biotech Veteran Michael Abrams as New CFO to Drive Growth | NRXP Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

NRXPNRX Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

NRX Pharmaceuticals Inc (NRXP) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

NRx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 13, 2024

NRx Pharmaceuticals delays Q3 results call to November 18 By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

NRx Pharmaceuticals delays Q3 results call to November 18 - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024 - XM

Nov 13, 2024
pulisher
Nov 13, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024 - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

NRx Pharmaceuticals (NRXP) Scheduled to Post Earnings on Thursday - Defense World

Nov 13, 2024
pulisher
Nov 08, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024 - BioSpace

Nov 08, 2024
pulisher
Nov 07, 2024

NRx Pharmaceuticals Sets Q3 2024 Earnings Call for November 14 | NRXP Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 01, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update L - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule - GlobeNewswire

Oct 31, 2024
pulisher
Oct 30, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq th - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Unde - GuruFocus.com

Oct 29, 2024
pulisher
Oct 26, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024 - GuruFocus.com

Oct 26, 2024
pulisher
Oct 26, 2024

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarte - GuruFocus.com

Oct 26, 2024
pulisher
Oct 26, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2 - GuruFocus.com

Oct 26, 2024
pulisher
Oct 24, 2024

NRx Pharmaceuticals, Inc. and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - Marketscreener.com

Oct 24, 2024
pulisher
Oct 23, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - StockTitan

Oct 23, 2024
pulisher
Oct 23, 2024

EF Hutton Acquisition Co. I Upgrades NRx Pharmaceuticals (NASDAQ:NRXP) to Strong-Buy - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Can Nrx combination unlock NMDA’s oomph in akathisia? - BioWorld Online

Oct 22, 2024
pulisher
Oct 21, 2024

EF Hutton sets stock target on NRx Pharma, cites suicide prevention - Investing.com India

Oct 21, 2024
pulisher
Oct 21, 2024

NRx started at buy by EF Hutton, cites suicide prevention focus - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

NRx started at buy by EF Hutton, cites suicide prevention focus (NASDAQ:NRXP) - Seeking Alpha

Oct 21, 2024
pulisher
Oct 16, 2024

NRx Pharmaceuticals secures additional $5 million funding By Investing.com - Investing.com Nigeria

Oct 16, 2024
pulisher
Oct 15, 2024

NRx Pharmaceuticals secures additional $5 million funding - Investing.com India

Oct 15, 2024
pulisher
Oct 14, 2024

NRx Pharmaceuticals announces CEO resignation and stockholder votes - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

NRx Pharmaceuticals announces CEO resignation and stockholder votes By Investing.com - Investing.com Nigeria

Oct 14, 2024
pulisher
Oct 12, 2024

NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions - Yahoo Finance

Oct 12, 2024
pulisher
Oct 11, 2024

NRx Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com

Oct 11, 2024
pulisher
Oct 10, 2024

NRXP stock touches 52-week low at $1.33 amid market challenges - Investing.com

Oct 10, 2024
pulisher
Oct 09, 2024

NRx Pharmaceuticals, Inc. announced that it has received $10 million in funding from Streeterville Capital, LLC - Marketscreener.com

Oct 09, 2024
pulisher
Oct 07, 2024

NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100 - MSN

Oct 07, 2024
pulisher
Oct 03, 2024

HOPE Therapeutics and NRx Pharmaceuticals to Acquire a Premier West Coast Interventional Psychiatric Clinic - citybiz

Oct 03, 2024
pulisher
Oct 03, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic - cnhinews.com

Oct 03, 2024
pulisher
Oct 02, 2024

NRXP stock touches 52-week low at $1.59 amid market challenges By Investing.com - Investing.com South Africa

Oct 02, 2024
pulisher
Oct 02, 2024

Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access - MyChesCo

Oct 02, 2024
pulisher
Oct 02, 2024

NRXP stock touches 52-week low at $1.59 amid market challenges - Investing.com Australia

Oct 02, 2024

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):